Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al
There may be additional risks that the Company considers immaterial, or which are unknown
2020;5(7):e134359134359
The remaining TRIUMPH trials (TRIUMPH-2 in obesity + T2D, TRIUMPH-3 in cardiovascular disease, TRIUMPH-OSA in sleep apnea, TRIUMPH-5 in liver disease, TRIUMPH-6 in chronic low back pain) will expand the label but are not required for the initial obesity approval
Wrote the paper: VG SR RHS DR PA KB
Deeper regenerative treatments, such as Peptide Therapy, HBOT, and Stem Cells, work at the cellular level over weeks and months to create profound, lasting changes to your body composition and biological age.